Vinge advises Anyfin in a capital procurement of approximately SEK 320 million

January 18, 2023 M&A

The new financing will be used in order to further strengthen Anyfin’s product portfolio on existing markets in Europe, to accelerate the development of new technology in order to help consumers to save money, and to improve the financial well-being of hundreds of thousands of Europeans.

Anyfin helps its customers to reduce their interest costs by refinancing original loans and providing better offers in respect of the customers’ loans.

Vinge’s team primarily consisted of Johan Larsson, Ellinor Wargenbrant and Nando Basic.



Vinge advises SAGA Diagnostics AB on convertible note issue

SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023

Vinge has advised private equity firm Stirling Square Capital Partners

Vinge has advised private equity firm Stirling Square Capital Partners in connection with its acquisition of a majority stake in Infobric, a leading provider of software solutions for the construction industry, from Summa Equity.
September 22, 2023